title: Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes.
abstract: The reactive aldehydes methylglyoxal and glyoxal, arise from enzymatic and non-enzymatic degradation of glucose, lipid and protein catabolism, and lipid peroxidation. In Type 1 diabetes mellitus (T1DM) where hyperglycemia, oxidative stress, and lipid peroxidation are common, these aldehydes may be elevated. These aldehydes form advanced glycation end products (AGEs) with proteins that are implicated in diabetic complications. We measured plasma methylglyoxal and glyoxal in young, complication-free T1DM patients and assessed activity of the ubiquitous membrane enzyme, Na+/K+ ATPase. A total of 56 patients with TIDM (DM group), 6-22 years, and 18 non-diabetics (ND group), 6-21 years, were enrolled. Mean plasma A1C (%) was higher in the DM group (8.5+/-1.3) as compared to the ND group (5.0+/-0.3). Using a novel liquid chromatography-mass spectrophotometry method, we found that mean plasma methylglyoxal (nmol/l) and glyoxal levels (nmol/l), respectively, were higher in the DM group (841.7+/-237.7, 1051.8+/-515.2) versus the ND group (439.2+/-90.1, 328.2+/-207.5). Erythrocyte membrane Na+/K+ ATPase activity (nmol NADH oxidized/min/mg protein) was elevated in the DM group (4.47+/-0.98) compared to the ND group (2.16+/-0.59). A1C correlated with plasma methylglyoxal and glyoxal, and both aldehydes correlated with each other. A high correlation of A1C with Na+/K+ ATPase activity, and a regression analysis showing A1C as a good predictor of activity of this enzyme, point to a role for glucose in membrane alteration. In complication-free patients, increased plasma methylglyoxal, plasma glyoxal, and erythrocyte Na+/K+ ATPase activity may foretell future diabetic complications, and emphasize a need for aggressive management.
authors.affiliation: Department of Laboratory Medicine, Memorial University, St. John's, Canada.
authors.forename: Yingchun
authors.initials: Y
authors.lastname: Han
authors.forename: Edward
authors.initials: E
authors.lastname: Randell
authors.forename: Sudesh
authors.initials: S
authors.lastname: Vasdev
authors.forename: Vicki
authors.initials: V
authors.lastname: Gill
authors.forename: Vereesh
authors.initials: V
authors.lastname: Gadag
authors.forename: Leigh Anne
authors.initials: LA
authors.lastname: Newhook
authors.forename: Marie
authors.initials: M
authors.lastname: Grant
authors.forename: Donna
authors.initials: D
authors.lastname: Hagerty
mesh_terms: D000293:Adolescent; D000328:Adult; D002462:Cell Membrane / Q000473:pathology*; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications / Q000473:pathology*; D003925:Diabetic Angiopathies / Q000473:pathology; D018450:Disease Progression; D004912:Erythrocytes / Q000473:pathology* / Q000648:ultrastructure; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006037:Glyoxal / Q000097:blood*; D006801:Humans; D008297:Male; D008954:Models, Biological; D011765:Pyruvaldehyde / Q000097:blood*; D000254:Sodium-Potassium-Exchanging ATPase / Q000097:blood / Q000378:metabolism
chemical_list: D006442:Glycated Hemoglobin; D006037:Glyoxal; D011765:Pyruvaldehyde; D000254:Sodium-Potassium-Exchanging ATPase; C517652:hemoglobin A1c protein, human